Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Dec 12, 2016 $29.27 $29.64 $28.26 $28.50 436 978
Dec 09, 2016 $31.74 $32.05 $29.39 $29.70 703 065
Dec 08, 2016 $31.00 $31.74 $30.33 $31.48 396 033
Dec 07, 2016 $33.48 $33.95 $30.61 $30.96 712 416
Dec 06, 2016 $34.99 $35.00 $32.45 $33.98 387 260
Dec 05, 2016 $37.22 $37.22 $33.28 $34.90 654 225
Dec 02, 2016 $34.80 $36.39 $34.40 $36.29 471 038
Dec 01, 2016 $34.12 $37.29 $33.24 $35.04 827 447
Nov 30, 2016 $36.72 $36.92 $33.61 $33.69 404 618
Nov 29, 2016 $36.66 $37.16 $35.83 $36.52 442 284
Nov 28, 2016 $37.76 $37.76 $36.35 $36.43 227 909
Nov 25, 2016 $38.34 $38.34 $37.21 $37.98 131 018
Nov 23, 2016 $36.54 $38.44 $35.67 $38.39 267 639
Nov 22, 2016 $37.87 $38.02 $36.22 $37.09 349 709
Nov 21, 2016 $37.83 $38.00 $36.42 $37.85 327 307
Nov 18, 2016 $37.74 $38.16 $36.44 $37.96 455 457
Nov 17, 2016 $39.32 $39.93 $37.87 $38.15 414 863
Nov 16, 2016 $40.62 $41.69 $38.51 $39.12 435 473
Nov 15, 2016 $40.10 $41.08 $39.28 $40.86 332 068
Nov 14, 2016 $39.28 $40.49 $38.57 $40.18 454 760
Nov 11, 2016 $36.09 $38.95 $35.51 $38.82 567 623
Nov 10, 2016 $34.60 $36.95 $33.99 $36.38 542 269
Nov 09, 2016 $30.53 $34.06 $30.45 $33.76 1 288 515
Nov 08, 2016 $27.19 $28.33 $27.10 $28.15 191 014
Nov 07, 2016 $27.30 $28.07 $26.48 $27.51 511 900
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT